.AstraZeneca has discussed a very early consider the performance of its internal antibody-drug conju...
.After announcing a stage 3 launch based on positive midstage results, iTeos and also GSK are actual...
.The FDA needs to be a lot more available as well as collaborative to release a rise in approvals of...
.It is actually an uncommonly busy Friday for biotech IPOs, along with Zenas BioPharma, MBX and Bica...
.Atea Pharmaceuticals' antiviral has actually fallen short another COVID-19 trial, yet the biotech s...
.Neurocrine Biosciences' mental illness program pivot has actually stopped working. The biotech was ...
.Sanofi has made a late entrance to the radioligand gathering, paying for 100 thousand europeans ($ ...
.After F2G's first effort to obtain a brand-new course of antifungal to market was actually hindered...
.Moderna has pledged to reduce R&D investing by $1.1 billion by 2027. The decision to shrink the ...
.Simply 4 months after Sanofi wager $80 million in ahead of time money on Fulcrum Therapies' losmapi...